Intravenous Vitamin C

DRUG4 trials

Sponsors

United States Army Institute of Surgical Research, Sidney Kimmel Cancer Center at Thomas Jefferson University, Jeanne Drisko, MD, CNS, FACN

Conditions

BurnsMetastatic Pancreatic CancerNon-Hodgkin LymphomaPancreatic Cancer

Phase 1

Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer

CompletedNCT00954525

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityMetastatic Pancreatic Cancer

Start: 2009-07-31End: 2011-12-31Updated: 2025-05-02

New Treatment Option for Pancreatic Cancer

CompletedNCT01364805

Jeanne Drisko, MD, CNS, FACNPancreatic Cancer

Start: 2011-04-30End: 2015-10-31Updated: 2018-06-19

Phase 2

Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL)

TerminatedNCT00626444

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityNon-Hodgkin Lymphoma

Start: 2008-02-29End: 2011-12-31Updated: 2025-05-16

Unknown Phase

The Effect of High Dose Vitamin C in Burn Patients

WithdrawnNCT00350077

United States Army Institute of Surgical ResearchBurns

Start: 2006-07-31End: 2008-03-31Updated: 2011-12-20

Related Papers

Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.

2012-01-17188 citations